Literature DB >> 30206672

High burden of skin sclerosis is associated with severe organ involvement in patients with systemic sclerosis and systemic sclerosis overlap syndrome.

Thapat Wannarong1, Chayawee Muangchan2.   

Abstract

The objective of this study is to investigate the impact of skin sclerosis burden on an internal organ involvement over a 1-year period, as measured by time-adjusted accrual-modified Rodnan skin score (TA-mRSS), and to evaluate association between TA-mRSS patterns and laboratory tests in patients with systemic sclerosis (SSc). This prospective study was conducted at Siriraj Hospital (Bangkok, Thailand) during the November 2013-November 2016. SSc patients by ACR/EULAR 2013 or ACR 1980 criteria were eligible. TA-mRSS was classified as low, intermediate, or high, and then compared between groups. Correlation between the arithmetic mean of laboratory tests and TA-mRSS was assessed by multiple linear regression analysis. A total of 118 patients, with 81.4% women, median (IQR) age 49.8 (43.8, 55.1) years, disease duration from onset of non-Raynaud symptoms to first visit of 3.3 (1, 6.8) years, 78% dcSSc, and 75.3% anti-Scl-70 positivity, were analyzed. TA-mRSS over 1 year ranged from 0 to 37.44. The high skin sclerosis burden group had a median TA-mRSS > 7.26 (> 67th percentile). Patients with high TA-mRSS were dcSSc, high initial and average mRSS, and had tendon friction rub, digital ischemic complications, usual interstitial pneumonia, diastolic dysfunction, gastrointestinal dysmotility, and low serum albumin. In multiple linear regression analysis, the arithmetic mean of hemoglobin (B = - 1.007, 95% CI - 1.779 to - 0.236), erythrocyte sedimentation rate (B = - 0.078, 95% CI - 0.126 to - 0.029), serum glutamic oxaloacetic transaminase (B = 0.073, 95% CI 0.026-0.12), creatine phosphokinase (B = 0.012, 95% CI 0.003-0.021), and albumin (B = - 4.117, 95% CI - 6.958 to - 1.276) were associated with TA-mRSS. This study found a higher cumulative course of mRSS over a 1-year period to be significantly associated with severe internal organ involvement.

Entities:  

Keywords:  Modified Rodnan skin score; Scleroderma; Severe organ involvement; Skin sclerosis; Systemic

Mesh:

Substances:

Year:  2018        PMID: 30206672     DOI: 10.1007/s00296-018-4156-4

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  28 in total

1.  Investigation of prognostic factors for skin sclerosis and lung function in Japanese patients with early systemic sclerosis: a multicentre prospective observational study.

Authors:  Minoru Hasegawa; Yoshihide Asano; Hirahito Endo; Manabu Fujimoto; Daisuke Goto; Hironobu Ihn; Katsumi Inoue; Osamu Ishikawa; Yasushi Kawaguchi; Masataka Kuwana; Yoshinao Muro; Fumihide Ogawa; Tetsuo Sasaki; Hiroki Takahashi; Sumiaki Tanaka; Kazuhiko Takehara; Shinichi Sato
Journal:  Rheumatology (Oxford)       Date:  2011-11-09       Impact factor: 7.580

2.  Incidence and predictors of cutaneous manifestations during the early course of systemic sclerosis: a 10-year longitudinal study from the EUSTAR database.

Authors:  Elina G Wirz; Veronika K Jaeger; Yannick Allanore; Gabriela Riemekasten; Eric Hachulla; Oliver Distler; Paolo Airò; Patricia E Carreira; Mohammed Tikly; Serena Vettori; Alexandra Balbir Gurman; Nemanja Damjanov; Ulf Müller-Ladner; Jörg Distler; Mangtao Li; Peter Häusermann; Ulrich A Walker
Journal:  Ann Rheum Dis       Date:  2015-07-31       Impact factor: 19.103

3.  Prediction of worsening of skin fibrosis in patients with diffuse cutaneous systemic sclerosis using the EUSTAR database.

Authors:  Britta Maurer; Nicole Graf; Beat A Michel; Ulf Müller-Ladner; László Czirják; Christopher P Denton; Alan Tyndall; Carola Metzig; Vivian Lanius; Dinesh Khanna; Oliver Distler
Journal:  Ann Rheum Dis       Date:  2014-06-30       Impact factor: 19.103

4.  Skin thickness progression rate: a predictor of mortality and early internal organ involvement in diffuse scleroderma.

Authors:  Robyn T Domsic; Tatiana Rodriguez-Reyna; Mary Lucas; Noreen Fertig; Thomas A Medsger
Journal:  Ann Rheum Dis       Date:  2010-08-02       Impact factor: 19.103

5.  Is serum albumin a marker of malnutrition in chronic disease? The scleroderma paradigm.

Authors:  Murray Baron; Marie Hudson; Russell Steele
Journal:  J Am Coll Nutr       Date:  2010-04       Impact factor: 3.169

6.  Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee.

Authors: 
Journal:  Arthritis Rheum       Date:  1980-05

7.  Clinical characteristics of scleroderma overlap syndromes: comparisons with pure scleroderma.

Authors:  Chingching Foocharoen; Sittichai Netwijitpan; Ajanee Mahakkanukrauh; Siraphop Suwannaroj; Ratanavadee Nanagara
Journal:  Int J Rheum Dis       Date:  2016-04-29       Impact factor: 2.454

8.  Long-term evaluation of colchicine in the treatment of scleroderma.

Authors:  D Alarcon-Segovia; F Ramos-Niembro; G Ibanez de Kasep; J Alcocer; R P Tamayo
Journal:  J Rheumatol       Date:  1979 Nov-Dec       Impact factor: 4.666

9.  Joint and tendon involvement predict disease progression in systemic sclerosis: a EUSTAR prospective study.

Authors:  Jérôme Avouac; Ulrich A Walker; Eric Hachulla; Gabriela Riemekasten; Giovanna Cuomo; Patricia E Carreira; Paola Caramaschi; Lidia P Ananieva; Marco Matucci-Cerinic; Laszlo Czirjak; Christopher Denton; Ulf Müller Ladner; Yannick Allanore
Journal:  Ann Rheum Dis       Date:  2014-08-27       Impact factor: 19.103

10.  Epidemiology and Survival of Systemic Sclerosis-Systemic Lupus Erythematosus Overlap Syndrome.

Authors:  Samar Alharbi; Zareen Ahmad; Arthur A Bookman; Zahi Touma; Jorge Sanchez-Guerrero; Nicholas Mitsakakis; Sindhu R Johnson
Journal:  J Rheumatol       Date:  2018-07-15       Impact factor: 4.666

View more
  3 in total

1.  State-of-the-art technologies provide new insights linking skin and blood vessel abnormalities in SSc-related disorders.

Authors:  Graham Dinsdale; Sarah Wilkinson; Jack Wilkinson; Tonia L Moore; Joanne B Manning; Michael Berks; Elizabeth Marjanovic; Mark Dickinson; Ariane L Herrick; Andrea K Murray
Journal:  Microvasc Res       Date:  2020-04-19       Impact factor: 3.514

2.  Persistent eosinophilia and associated organ involvement in Thai patients with systemic sclerosis: Data from the Siriraj scleroderma cohort.

Authors:  Somsak Punjasamanvong; Chayawee Muangchan
Journal:  Arch Rheumatol       Date:  2021-10-18       Impact factor: 1.472

3.  Anemia Is an Indicator for Worse Organ Damage Trajectories in Patients with Systemic Sclerosis: A Retrospective Study.

Authors:  Zhaohua Li; Dan Xu; Xintong Jiang; Ting Li; Yin Su; Rong Mu
Journal:  J Clin Med       Date:  2022-08-26       Impact factor: 4.964

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.